Research Paper Volume 11, Issue 8 pp 2281—2294

Figure 4. T-BSA upregulated the phosphorylation level of Erk1/2 and eIF4E through ZIP9/Gnα11. (A–C) The ratio of phosphorylated/total levels of P38 (A), JNK (B), and Erk1/2 (C) detected in HT22 cells pre-treated with nc-shRNA or Gnα11-shRNA using Flowmetric Luminex xMAP^® assay (n=5). (D–F) Western blotting for the phosphorylated/total levels of Erk1/2 and eIF4E induced by T-BSA pre-treated with nc-shRNA, ZIP9-shRNA, or Gnα11-shRNA (n=5). (G–J) Immunofluorescence staining for the phosphorylation level of Erk1/2 and eIF4E induced by T-BSA pre-treated with nc-shRNA, ZIP9-shRNA or Gnα11-shRNA (n=4, scale bars = 20 μm). (n.s.: non-significant; * P < 0.05; ** P < 0.01).